Development and validation of a nomogram to predict symptomatic recurrence following laparoscopic adenomyomectomy - Takeaways - MDSpire

Development and validation of a nomogram to predict symptomatic recurrence following laparoscopic adenomyomectomy

  • By

  • Yiwen Yao

  • Jilan Jiang

  • Jin Yu

  • Yeping Yang

  • Wenyu Li

  • Feng Sun

  • July 16, 2026

Share

  • 1

    A nomogram was developed to predict symptomatic recurrence after laparoscopic adenomyomectomy using retrospective data from 484 patients.

  • 2

    Independent predictors of recurrence included previous surgical history of ovarian endometrioma and preoperative CA125 levels.

  • 3

    The nomogram demonstrated good discriminatory ability with an area under the curve of 0.776, indicating effective risk estimation.

  • 4

    Calibration curves showed good performance, and decision curve analysis indicated high net benefit for predicted probabilities between 0% and 60%.

  • 5

    The study emphasizes the need for multicenter external validation to confirm the clinical utility of the nomogram.

Original Source(s)

Development and validation of a nomogram to predict symptomatic recurrence following laparoscopic adenomyomectomy

  • by Yiwen Yao, Jilan Jiang, Jin Yu, Yeping Yang, Wenyu Li, Feng Sun

  • July 16, 2026

Related Content

Advantages of Using Minimal Ethanol Volume with Retention in Transvaginal Ethanol Sclerotherapy for Endometriomas

Superficial heat therapy in women’s health

A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways